Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018))

Dutch NIPT Consortium

doi:https://doi.org/10.1016/j.ajhg.2022.06.003

Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018))

Dutch NIPT Consortium

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

Abstract

(The American Journal of Human Genetics 109, 1140–1152; June 2, 2022) In the originally published version of this article, in Table 3, the column heading “Placenta biopsies” was placed erroneously under “Available clinical follow-up” instead of under “Available cytogenic follow-up.” The authors apologize for this error, which has been corrected online.

Original language	English
Pages (from-to)	1344
Number of pages	1
Journal	American journal of human genetics
Volume	109
Issue number	7
DOIs	https://doi.org/10.1016/j.ajhg.2022.06.003 https://doi.org/10.1016/j.ajhg.2022.06.003
Publication status	Published - 7 Jul 2022

Access to Document

Cite this

Dutch NIPT Consortium (2022). Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018)). American journal of human genetics, 109(7), 1344. https://doi.org/10.1016/j.ajhg.2022.06.003, https://doi.org/10.1016/j.ajhg.2022.06.003

Dutch NIPT Consortium. / Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing : Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018)). In: American journal of human genetics. 2022 ; Vol. 109, No. 7. pp. 1344.

@article{12c474f8e766401a856b5087dc0a7a1a,

title = "Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018))",

abstract = "(The American Journal of Human Genetics 109, 1140–1152; June 2, 2022) In the originally published version of this article, in Table 3, the column heading “Placenta biopsies” was placed erroneously under “Available clinical follow-up” instead of under “Available cytogenic follow-up.” The authors apologize for this error, which has been corrected online.",

author = "{Dutch NIPT Consortium} and {van Prooyen Schuurman}, Lisanne and Sistermans, {Erik A.} and {van Opstal}, Diane and Lidewij Henneman and Bekker, {Mireille N.} and Bax, {Caroline J.} and Pieters, {Mijntje J.} and Katelijne Bouman and {de Munnik}, Sonja and {den Hollander}, {Nicolette S.} and Diderich, {Karin E. M.} and Faas, {Brigitte H. W.} and Ilse Feenstra and Go, {Attie T. J. I.} and Hoffer, {Mari{\"e}tte J. V.} and Marieke Joosten and Komdeur, {Fenne L.} and Lichtenbelt, {Klaske D.} and Lombardi, {Maria P.} and Polak, {Marike G.} and Jehee, {Fernanda S.} and Heleen Schuring-Blom and Stevens, {Servi J. C.} and Srebniak, {Malgorzata I.} and Suijkerbuijk, {Ron F.} and Tan-Sindhunata, {Gita M.} and {van der Meij}, {Karuna R. M.} and {van Maarle}, {Merel C.} and Vivian Vernimmen and {van Zelderen-Bhola}, {Shama L.} and {van Ravesteyn}, {Nicolien T.} and Knapen, {Maarten F. C. M.} and Macville, {Merryn V. E.} and Galjaard, {Robert-Jan H.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s)",

year = "2022",

month = jul,

day = "7",

doi = "https://doi.org/10.1016/j.ajhg.2022.06.003",

language = "English",

volume = "109",

pages = "1344",

journal = "American journal of human genetics",

issn = "0002-9297",

publisher = "Cell Press",

number = "7",

}

Dutch NIPT Consortium 2022, 'Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018))', American journal of human genetics, vol. 109, no. 7, pp. 1344. https://doi.org/10.1016/j.ajhg.2022.06.003, https://doi.org/10.1016/j.ajhg.2022.06.003

Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018)). / Dutch NIPT Consortium.
In: American journal of human genetics, Vol. 109, No. 7, 07.07.2022, p. 1344.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing

T2 - Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018))

AU - Dutch NIPT Consortium

AU - van Prooyen Schuurman, Lisanne

AU - Sistermans, Erik A.

AU - van Opstal, Diane

AU - Henneman, Lidewij

AU - Bekker, Mireille N.

AU - Bax, Caroline J.

AU - Pieters, Mijntje J.

AU - Bouman, Katelijne

AU - de Munnik, Sonja

AU - den Hollander, Nicolette S.

AU - Diderich, Karin E. M.

AU - Faas, Brigitte H. W.

AU - Feenstra, Ilse

AU - Go, Attie T. J. I.

AU - Hoffer, Mariëtte J. V.

AU - Joosten, Marieke

AU - Komdeur, Fenne L.

AU - Lichtenbelt, Klaske D.

AU - Lombardi, Maria P.

AU - Polak, Marike G.

AU - Jehee, Fernanda S.

AU - Schuring-Blom, Heleen

AU - Stevens, Servi J. C.

AU - Srebniak, Malgorzata I.

AU - Suijkerbuijk, Ron F.

AU - Tan-Sindhunata, Gita M.

AU - van der Meij, Karuna R. M.

AU - van Maarle, Merel C.

AU - Vernimmen, Vivian

AU - van Zelderen-Bhola, Shama L.

AU - van Ravesteyn, Nicolien T.

AU - Knapen, Maarten F. C. M.

AU - Macville, Merryn V. E.

AU - Galjaard, Robert-Jan H.

PY - 2022/7/7

Y1 - 2022/7/7

N2 - (The American Journal of Human Genetics 109, 1140–1152; June 2, 2022) In the originally published version of this article, in Table 3, the column heading “Placenta biopsies” was placed erroneously under “Available clinical follow-up” instead of under “Available cytogenic follow-up.” The authors apologize for this error, which has been corrected online.

AB - (The American Journal of Human Genetics 109, 1140–1152; June 2, 2022) In the originally published version of this article, in Table 3, the column heading “Placenta biopsies” was placed erroneously under “Available clinical follow-up” instead of under “Available cytogenic follow-up.” The authors apologize for this error, which has been corrected online.

UR - http://www.scopus.com/inward/record.url?scp=85133740743&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.ajhg.2022.06.003

DO - https://doi.org/10.1016/j.ajhg.2022.06.003

M3 - Article

C2 - 35803237

SN - 0002-9297

VL - 109

SP - 1344

JO - American journal of human genetics

JF - American journal of human genetics

IS - 7

ER -

Dutch NIPT Consortium. Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018)). American journal of human genetics. 2022 Jul 7;109(7):1344. doi: https://doi.org/10.1016/j.ajhg.2022.06.003, https://doi.org/10.1016/j.ajhg.2022.06.003

Abstract

Access to Document

Other files and links

Cite this